The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations ; volume:37 ; number:12 ; day:16 ; month:10 ; year:2023 ; pages:2526-2531 ; date:12.2023
Leukemia ; 37, Heft 12 (16.10.2023), 2526-2531, 12.2023
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-023-02060-2
- URN
-
urn:nbn:de:101:1-2024021413104422654878
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhao, Duoduo
- Rohde, Christian
- Göllner, Stefanie
- Zhou, Fengbiao
- Pauli, Cornelius
- Blank, Maximilian Felix
- Zinz, Rafael
- Grab, Anna Luise
- Poos, Alexandra
- John, Lukas
- Huhn, Stefanie
- Raab, Marc-Steffen
- Müller-Tidow, Carsten
- Weinhold, Niels
- SpringerLink (Online service)
Other Objects (12)
The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma
The role of small nucleolar Ribonucleoprotein complexes in lung cancer
Leukemia stem cell fates are determined by DNA methylation levels
Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening
Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes
Myeloische Neoplasien
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study
The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma
The role of small nucleolar Ribonucleoprotein complexes in lung cancer
Leukemia stem cell fates are determined by DNA methylation levels
Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening
Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes
Myeloische Neoplasien
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study
The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma
The role of small nucleolar Ribonucleoprotein complexes in lung cancer
Leukemia stem cell fates are determined by DNA methylation levels
Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening
Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes
Myeloische Neoplasien
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting